Fowler John Franklin

Other

US·SEC (Form 4)

Kezar Life Sciences, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the detailed record of transactions filed by Fowler John Franklin. Insider active across 1 companies, notably Kezar Life Sciences, Inc.. Aggregated, 2 reports have been recorded. The latest transaction was disclosed on 14 December 2021 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.

Declarations2 total

Executives◇OptionsKKezar Life Sciences, Inc.22SEC

F

Fowler John FranklinCEO

€6,1417,700 shares@ €0.7975100.0% of flow

Common Stock

SEC:0001209191-21-069814·14 Dec 2021

SEC ↗

Executives◇OptionsKKezar Life Sciences, Inc.32SEC

F

Fowler John FranklinCEO

€6,1417,700 shares@ €0.79750.011% mcap50.0% of flow